What’s behind Southeast Asia’s hesitancy towards China-made vaccines?

While China has so far supplied 190 million doses of its home-grown Covid-19 inoculations to Southeast Asia, making it a primary region for Beijing’s vaccine diplomacy, public perception towards the likes of Sinovac and Sinopharm are largely negative.An examination of Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam reveals some common factors driving this selective hesitancy, despite the two Chinese-made vaccines being by far the most readily available in the region…


See also  Virginia, Virginia Tech Top 25 clash highlights ACC play

Leave a Reply